A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells. - sprookjes - yvandenbroek - TriplyDB

A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells.

A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells.

http://www.wikidata.org/entity/Q35082328

about

Epigenetic effects of green tea polyphenols in cancer Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene Therapeutic Targeting of Telomerase Regulation of the Telomerase Reverse Transcriptase Subunit through Epigenetic Mechanisms Epigenetic diet: impact on the epigenome and cancer Therapeutic targeting of replicative immortality Reducing Breast Cancer Recurrence: The Role of Dietary Polyphenolics Cancer Preventive Activities of Tea Catechins Effects of physiological levels of the green tea extract epigallocatechin-3-gallate on breast cancer cells Induction of Apoptosis in Pancreatic Cancer Cells by CDDO-Me Involves Repression of Telomerase through Epigenetic Pathways.Regulation of the human catalytic subunit of telomerase (hTERT).Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention.Epigenomics of ovarian cancer and its chemoprevention.Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer Epigenetic activities of flavonoids in the prevention and treatment of cancer Phytochemical antioxidants modulate mammalian cellular epigenome: implications in health and disease.Homeostatic imbalance and colon cancer: the dynamic epigenetic interplay of inflammation, environmental toxins, and chemopreventive plant compounds Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.Going Green: The Role of the Green Tea Component EGCG in Chemoprevention.Reduction in promotor methylation utilizing EGCG (epigallocatechin-3-gallate) restores RXRα expression in human colon cancer cells.Epigenetic reactivation of p21CIP1/WAF1 and KLOTHO by a combination of bioactive dietary supplements is partially ERα-dependent in ERα-negative human breast cancer cells.Plant phytochemicals as epigenetic modulators: role in cancer chemoprevention.Pharmaceutical regulation of telomerase and its clinical potential Impact of Epigenetic Dietary Components on Cancer through Histone Modifications.Centchroman altered the expressions of tumor-related genes through active chromatin modifications in mammary cancer.Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review.Effects of Tea Catechins on Cancer Signaling Pathways.Procyanidins from evening primrose (Oenothera paradoxa) defatted seeds inhibit invasiveness of breast cancer cells and modulate the expression of selected genes involved in angiogenesis, metastasis, and apoptosis.Transforming Cancer Epigenetics Using Nutritive Approaches and Non-coding RNAs.Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ERα expression.Epigenetics of Skin Cancer: Interventions by selected bioactive Phytochemicals.Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell Lines.Polyphenols as Promising Drugs against Main Breast Cancer Signatures.Telomerase Inhibitors from Natural Products and Their Anticancer Potential.Sulforaphane and Epigallocatechin Gallate Restore Estrogen Receptor Expression by Modulating Epigenetic Events in the Breast Cancer Cell Line MDA-MB-231: A Systematic Review and Meta-Analysis.In vitro Biological Effects of Sulforaphane (SFN), Epigallocatechin-3-gallate (EGCG), and Curcumin on Breast Cancer Cells: A Systematic Review of the Literature.Epigenetics, Plant (Poly)phenolics, and Cancer Prevention

P2860

Q24568216-58C506EE-3A84-438B-B79C-F7C3A7B40E2E Q26739925-61A3C3EA-B5BC-483C-87F5-A3F20D4FEB71 Q26741736-4E793B2C-7E54-4F3C-8E3F-D1A175FB74AD Q26744572-B9119EA6-D63E-40BB-8178-9A98AE1D7403 Q27022002-5136F74A-F834-45FF-B786-13CB1EF0A73F Q27027457-00AC7883-C1D5-4FE9-ABE1-953F24FF7FDB Q28075634-A94D14FD-C637-4D47-A035-EB4620283C10 Q28076334-ACD7DEBA-E22C-4877-A66C-F4C09AC123D4 Q33605964-B692977F-68EF-47B3-956E-75B87991EFDC Q34069749-7D9FA2A1-CE59-4D89-8335-526319646F81 Q34180715-B1FDDD1D-F3CC-4DCB-AC96-67CE57D8E1D4 Q34291226-297F72A7-B005-428A-A369-8F8387282EBD Q34339224-6C74B95A-F651-40D2-BC41-407E9D44AB84 Q35711392-89E04661-4D31-4F74-8E7B-9ADEB1039DBA Q35803971-0F59D567-381C-4AA6-B851-BA1129BA05C0 Q35835175-96C51EF0-1AFA-483C-B5DA-80933472B23B Q35965132-1326D7EE-262F-43F9-B5C8-CD6DBFF0CE51 Q36002120-EF1D17E4-E40B-47F8-971E-1EA8EBA005EA Q36624258-E4F49DA0-FCD0-463F-9CFC-0237F3CA14FF Q37198232-7A8F75B6-F633-43FF-8E9C-A5CC81372292 Q37376545-40ABF1BC-6CB8-41C7-BD31-6C6FD1CBB85C Q37462347-71650A6A-2446-4350-BA9D-1134422121F8 Q37469412-F20D789E-B055-4236-A5DF-E82AD21BC29A Q37942633-5461734A-36DA-472E-9A6C-A1D505FCF8D7 Q38428453-83721E08-4937-4F5F-AFA1-B1D2722CA249 Q38828009-F4255E43-DA6A-448A-B912-1EEC16C62540 Q38958946-8A46E84F-3000-4985-B357-15E37B03B084 Q39039219-FE907D71-F8B8-43CE-81A6-7B7D4C5E3E0F Q39085358-3D823C7F-F0D7-45CB-BDDB-03B32723786D Q39125760-88BBA03B-5207-4B50-A100-5F32136DAE5F Q41516113-C2FD76FC-BD92-46A4-B0D4-DBC96EB9897F Q42516254-6054F265-B69A-40C1-AFA1-8DFBE38046D8 Q46840249-BFB84AB7-31FA-49C5-A11D-166F11DEDD30 Q47136288-EB19BB6D-8C06-4E94-A894-A314F33B89E2 Q47265475-41496143-0A4D-4C7D-A2D6-8799EBD3A08C Q50081425-10ED7423-C558-41D7-9653-866BC6407F88 Q50222488-683E3B9E-1442-4421-9699-54658A329865 Q57782660-1464B4FC-3E6E-4338-A29B-60CE058E6BD0

P2860

A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells.

http://www.wikidata.org/entity/Q35082328

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

A novel prodrug of epigallocat ...... in human breast cancer cells.

@ast

A novel prodrug of epigallocat ...... in human breast cancer cells.

@en

type

label

A novel prodrug of epigallocat ...... in human breast cancer cells.

@ast

A novel prodrug of epigallocat ...... in human breast cancer cells.

@en

prefLabel

A novel prodrug of epigallocat ...... in human breast cancer cells.

@ast

A novel prodrug of epigallocat ...... in human breast cancer cells.

@en

P1433

Q35082328-4334311E-9863-45F6-B198-8EB194757A51

P1476

Q35082328-8490078D-70AE-44B0-8FAD-E321180CD735

P2093

Q35082328-08FEE7CF-4601-4D6B-A960-B998A19ED29C

Q35082328-42991EB6-D8ED-4F79-B685-ED04F1F81DD3

Q35082328-48411B46-7F6D-4428-9756-ABB819912F28

Q35082328-94409E64-21C7-4D5A-8D6A-A73D418523F2

P2860

Q35082328-00641079-1940-46C2-B603-2C56C4026BCA

Q35082328-0618AC3E-9857-45DB-864C-C8FD11FB7437

Q35082328-0B36B008-4385-4FC1-9E9A-6DDE1CC6F55B

Q35082328-0E062B2E-EA32-42C8-8DD5-6248B2B95151

Q35082328-146BFBED-593F-44B9-9E60-B13A1612204B

Q35082328-14FF9DE1-2348-4A3B-AD8C-5ED106577896

Q35082328-167F19F2-F7F5-4D5D-B03E-880E1A4A6F60

Q35082328-1EDC949F-F255-4286-93C4-BE94D656B37E

Q35082328-20855EF8-8CEA-483E-8D3D-EFBA3BF37512

Q35082328-27A4253B-91C7-4F3D-84BE-0253A668367A

P304

Q35082328-7C42F7E8-718D-47F9-88AD-056D4855B1CF

P31

Q35082328-6BB40467-11CE-4467-9EBB-6FEDA68B6341

P356

Q35082328-68156BF2-CE87-4A2B-BFE5-539AB1884D4E

P433

Q35082328-E66E5E52-A956-47CA-B7F3-9429AA992B93

P478

Q35082328-A1D8E311-684B-41C3-9EE4-387A1E20A49D

P577

Q35082328-B8797D14-3B5C-44D6-8BB1-1573A52DDB10

P698

Q35082328-4F23F8F5-EB99-4236-8723-811335AEFB65

P932

Q35082328-F462188C-E9AD-4ADB-BF62-4C145979D266

P356

1940-6207.CAPR-11-0009

P1433

Cancer Prevention Research

P1476

A novel prodrug of epigallocat ...... in human breast cancer cells.

@en

P2093

Shweta N Patel

http://www.w3.org/2001/XMLSchema#string

Syed M Meeran

http://www.w3.org/2001/XMLSchema#string

Tak-Hang Chan

http://www.w3.org/2001/XMLSchema#string

Trygve O Tollefsbol

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of Mad as a repressor of the human telomerase (hTERT) gene

Dietary polyphenols may affect DNA methylation

Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers

Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols

Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo

Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines

Antitumor activity of novel fluoro-substituted (-)-epigallocatechin-3-gallate analogs.

The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma.

Cancer chemoprevention by tea polyphenols.

Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells

P304

1243-1254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1940-6207.CAPR-11-0009

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21411498

http://www.w3.org/2001/XMLSchema#string

P932

3128170

http://www.w3.org/2001/XMLSchema#string